Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression
Glioma is a primary intracranial malignant tumor with poor prognosis, and its pathogenesis is unclear. This study discussed the impact of p53/lncRNA plasmacytoma variant translocation 1 (lncRNA PVT1)/transforming growth factor beta (TGF-β)/Smad axis on the biological characteristics of glioma. Gliom...
Main Authors: | Zhang Li, Ming Li, Pengcheng Xia, Lili Wang, Zhiming Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Cancer Biology & Therapy |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/15384047.2022.2042160 |
Similar Items
-
Cyclin‐dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial‐mesenchymal transition‐like process in glioma by activating TGFβ/SMAD signaling
by: Fan Feng, et al.
Published: (2023-03-01) -
Long noncoding RNA Smyca coactivates TGF-β/Smad and Myc pathways to drive tumor progression
by: Hsin-Yi Chen, et al.
Published: (2022-07-01) -
Strontium Regulates the Proliferation and Differentiation of Isolated Primary Bovine Chondrocytes via the TGFβ/SMAD Pathway
by: Siqi Liu, et al.
Published: (2022-05-01) -
The Anti-Rheumatic Drug, Leflunomide, Induces Nephrotoxicity in Mice via Upregulation of TGFβ-Mediated p53/Smad2/3 Signaling
by: Alhanouf A. Aljohani, et al.
Published: (2022-05-01) -
TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
by: Lih-Fhung Hiew, et al.
Published: (2021-06-01)